Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cells | 18 | 2022 | 359 | 5.070 |
Why?
|
Neoplasms | 29 | 2022 | 2179 | 4.580 |
Why?
|
Leukemia | 9 | 2022 | 208 | 4.110 |
Why?
|
Aging | 18 | 2022 | 1677 | 3.550 |
Why?
|
Clonal Evolution | 6 | 2022 | 26 | 3.140 |
Why?
|
Mutation | 34 | 2022 | 3457 | 3.010 |
Why?
|
Cell Transformation, Neoplastic | 11 | 2023 | 317 | 2.690 |
Why?
|
Cell Cycle Proteins | 29 | 2016 | 565 | 2.360 |
Why?
|
Biological Evolution | 6 | 2020 | 443 | 2.060 |
Why?
|
Models, Biological | 12 | 2020 | 1715 | 2.030 |
Why?
|
DNA-Binding Proteins | 32 | 2022 | 1346 | 1.980 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2022 | 671 | 1.950 |
Why?
|
Leukemia, Myeloid, Acute | 7 | 2022 | 532 | 1.920 |
Why?
|
fms-Like Tyrosine Kinase 3 | 4 | 2022 | 42 | 1.890 |
Why?
|
Fusion Proteins, bcr-abl | 7 | 2015 | 61 | 1.670 |
Why?
|
Tumor Microenvironment | 5 | 2022 | 454 | 1.600 |
Why?
|
Stem Cells | 10 | 2020 | 559 | 1.570 |
Why?
|
Selection, Genetic | 9 | 2021 | 252 | 1.500 |
Why?
|
Animals | 96 | 2023 | 33399 | 1.440 |
Why?
|
Carcinogenesis | 4 | 2022 | 182 | 1.430 |
Why?
|
Mice | 67 | 2023 | 15528 | 1.390 |
Why?
|
Genetic Fitness | 6 | 2021 | 55 | 1.390 |
Why?
|
Protein Kinase Inhibitors | 8 | 2022 | 811 | 1.350 |
Why?
|
Mutation Rate | 4 | 2019 | 25 | 1.340 |
Why?
|
Hematopoiesis | 5 | 2022 | 175 | 1.330 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 | 2014 | 93 | 1.310 |
Why?
|
Apoptosis | 24 | 2022 | 2484 | 1.300 |
Why?
|
Transcription Factors | 25 | 2005 | 1570 | 1.260 |
Why?
|
Down Syndrome | 3 | 2022 | 356 | 1.250 |
Why?
|
Hematologic Neoplasms | 3 | 2015 | 133 | 1.210 |
Why?
|
RNA, Small Interfering | 9 | 2016 | 564 | 1.160 |
Why?
|
E2F Transcription Factors | 24 | 2006 | 55 | 1.150 |
Why?
|
Biomarkers, Tumor | 5 | 2019 | 1059 | 1.140 |
Why?
|
Nuclear Proteins | 10 | 2015 | 597 | 1.130 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2019 | 968 | 1.110 |
Why?
|
Adaptation, Physiological | 5 | 2019 | 502 | 1.100 |
Why?
|
E2F1 Transcription Factor | 20 | 2011 | 56 | 1.080 |
Why?
|
ErbB Receptors | 5 | 2023 | 569 | 1.050 |
Why?
|
Cell Proliferation | 16 | 2021 | 2275 | 1.020 |
Why?
|
Tankyrases | 2 | 2016 | 14 | 1.000 |
Why?
|
Radiation, Ionizing | 4 | 2015 | 74 | 1.000 |
Why?
|
Neoplastic Stem Cells | 7 | 2021 | 336 | 0.980 |
Why?
|
Bone Marrow Transplantation | 7 | 2020 | 244 | 0.960 |
Why?
|
DNA Replication | 9 | 2007 | 211 | 0.930 |
Why?
|
Cell Division | 11 | 2020 | 776 | 0.910 |
Why?
|
Tumor Suppressor Protein p53 | 9 | 2013 | 455 | 0.910 |
Why?
|
Genetic Predisposition to Disease | 3 | 2023 | 2275 | 0.900 |
Why?
|
Humans | 99 | 2023 | 119032 | 0.900 |
Why?
|
Antineoplastic Agents | 7 | 2019 | 1974 | 0.890 |
Why?
|
Cellular Senescence | 4 | 2014 | 151 | 0.890 |
Why?
|
Dioxygenases | 1 | 2022 | 26 | 0.870 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 2022 | 11 | 0.870 |
Why?
|
Lung Neoplasms | 7 | 2023 | 2220 | 0.870 |
Why?
|
Clone Cells | 6 | 2023 | 248 | 0.870 |
Why?
|
Skin | 5 | 2023 | 657 | 0.870 |
Why?
|
Retinoblastoma Protein | 11 | 2006 | 52 | 0.860 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 1 | 2022 | 27 | 0.850 |
Why?
|
Cell Line, Tumor | 13 | 2022 | 2851 | 0.850 |
Why?
|
Models, Genetic | 4 | 2019 | 595 | 0.830 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2015 | 407 | 0.820 |
Why?
|
Longevity | 2 | 2020 | 151 | 0.820 |
Why?
|
Glutamine | 2 | 2019 | 88 | 0.820 |
Why?
|
Cell Cycle | 17 | 2021 | 550 | 0.810 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2021 | 34 | 0.800 |
Why?
|
Tumor Suppressor Proteins | 8 | 2012 | 289 | 0.790 |
Why?
|
Benzothiazoles | 2 | 2017 | 37 | 0.760 |
Why?
|
Mice, Transgenic | 15 | 2021 | 2025 | 0.740 |
Why?
|
Wnt Proteins | 2 | 2012 | 140 | 0.740 |
Why?
|
Phenylurea Compounds | 2 | 2017 | 85 | 0.730 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 185 | 0.730 |
Why?
|
Mice, Inbred BALB C | 13 | 2021 | 1206 | 0.720 |
Why?
|
Interleukin-1beta | 2 | 2021 | 379 | 0.710 |
Why?
|
T-Lymphocytes | 7 | 2016 | 1774 | 0.710 |
Why?
|
Carrier Proteins | 16 | 2000 | 726 | 0.700 |
Why?
|
Oxidation-Reduction | 3 | 2019 | 940 | 0.700 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 356 | 0.700 |
Why?
|
Skin Aging | 1 | 2019 | 20 | 0.690 |
Why?
|
Precursor Cells, B-Lymphoid | 2 | 2017 | 33 | 0.690 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2019 | 740 | 0.680 |
Why?
|
Body Size | 1 | 2019 | 94 | 0.680 |
Why?
|
Bone Marrow Cells | 4 | 2020 | 273 | 0.670 |
Why?
|
Urea | 1 | 2019 | 77 | 0.670 |
Why?
|
Mitochondria | 4 | 2019 | 786 | 0.650 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 381 | 0.650 |
Why?
|
Cell Survival | 8 | 2019 | 1047 | 0.640 |
Why?
|
Evolution, Molecular | 4 | 2020 | 454 | 0.640 |
Why?
|
Benzeneacetamides | 1 | 2017 | 7 | 0.630 |
Why?
|
Glutaminase | 1 | 2017 | 9 | 0.620 |
Why?
|
RNA Interference | 3 | 2016 | 460 | 0.620 |
Why?
|
Quantitative Trait Loci | 1 | 2020 | 324 | 0.620 |
Why?
|
Thiadiazoles | 1 | 2017 | 21 | 0.610 |
Why?
|
Phenotype | 9 | 2021 | 3004 | 0.610 |
Why?
|
Folic Acid Deficiency | 1 | 2017 | 48 | 0.600 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 2 | 2016 | 62 | 0.600 |
Why?
|
Genetic Vectors | 10 | 2011 | 302 | 0.600 |
Why?
|
Signal Transduction | 20 | 2021 | 4713 | 0.590 |
Why?
|
Esophagus | 1 | 2019 | 237 | 0.590 |
Why?
|
Mice, Inbred C57BL | 19 | 2021 | 4914 | 0.590 |
Why?
|
Skin Neoplasms | 2 | 2023 | 762 | 0.580 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2015 | 115 | 0.580 |
Why?
|
Mice, Knockout | 14 | 2021 | 2680 | 0.580 |
Why?
|
Adenoviridae | 13 | 2013 | 191 | 0.580 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2016 | 41 | 0.570 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 49 | 0.570 |
Why?
|
Folic Acid | 1 | 2017 | 161 | 0.570 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 360 | 0.570 |
Why?
|
Inflammation | 7 | 2022 | 2571 | 0.570 |
Why?
|
S Phase | 15 | 2012 | 74 | 0.570 |
Why?
|
Mutagens | 1 | 2015 | 17 | 0.540 |
Why?
|
DNA | 7 | 2011 | 1388 | 0.530 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2015 | 66 | 0.520 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2015 | 16 | 0.520 |
Why?
|
Multipotent Stem Cells | 1 | 2015 | 18 | 0.520 |
Why?
|
Oligomycins | 1 | 2014 | 8 | 0.520 |
Why?
|
Islets of Langerhans | 3 | 2008 | 739 | 0.520 |
Why?
|
Genomics | 4 | 2020 | 705 | 0.520 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 18 | 0.510 |
Why?
|
Patient-Specific Modeling | 1 | 2014 | 37 | 0.510 |
Why?
|
Cell Differentiation | 13 | 2021 | 1753 | 0.500 |
Why?
|
Energy Metabolism | 2 | 2019 | 767 | 0.500 |
Why?
|
Enzyme Inhibitors | 4 | 2016 | 829 | 0.500 |
Why?
|
Genes, p53 | 4 | 2012 | 64 | 0.490 |
Why?
|
Receptors, Notch | 1 | 2015 | 85 | 0.490 |
Why?
|
Cell Line | 21 | 2021 | 2707 | 0.490 |
Why?
|
Leukemia, Experimental | 2 | 2011 | 27 | 0.490 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2014 | 1390 | 0.480 |
Why?
|
Thioguanine | 2 | 2011 | 20 | 0.480 |
Why?
|
Cells, Cultured | 13 | 2022 | 4081 | 0.470 |
Why?
|
Dietary Supplements | 1 | 2017 | 467 | 0.470 |
Why?
|
Antigens | 3 | 2005 | 320 | 0.460 |
Why?
|
Receptors, Virus | 4 | 2001 | 78 | 0.450 |
Why?
|
Diabetes Mellitus | 3 | 2008 | 945 | 0.450 |
Why?
|
DNA Repair | 2 | 2012 | 198 | 0.450 |
Why?
|
Oncogenes | 3 | 2009 | 111 | 0.440 |
Why?
|
Cytarabine | 1 | 2012 | 53 | 0.410 |
Why?
|
Mice, Inbred NOD | 4 | 2019 | 574 | 0.410 |
Why?
|
Oxidative Phosphorylation | 3 | 2022 | 156 | 0.400 |
Why?
|
Proto-Oncogene Proteins | 6 | 2022 | 618 | 0.400 |
Why?
|
Myeloproliferative Disorders | 1 | 2011 | 26 | 0.390 |
Why?
|
Cyclin-Dependent Kinases | 9 | 2006 | 111 | 0.390 |
Why?
|
Lymphopoiesis | 1 | 2010 | 23 | 0.380 |
Why?
|
Adenoviruses, Human | 2 | 2011 | 24 | 0.380 |
Why?
|
Cell Separation | 2 | 2009 | 296 | 0.380 |
Why?
|
Philadelphia Chromosome | 1 | 2010 | 15 | 0.380 |
Why?
|
G1 Phase | 8 | 2002 | 68 | 0.380 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2019 | 1167 | 0.370 |
Why?
|
Homeostasis | 3 | 2021 | 594 | 0.370 |
Why?
|
Transcription, Genetic | 6 | 2006 | 1323 | 0.370 |
Why?
|
Flow Cytometry | 7 | 2014 | 1085 | 0.370 |
Why?
|
Bone Marrow | 3 | 2019 | 255 | 0.370 |
Why?
|
NFATC Transcription Factors | 1 | 2010 | 82 | 0.360 |
Why?
|
Age Factors | 6 | 2019 | 2995 | 0.360 |
Why?
|
Gene Expression Regulation | 15 | 2007 | 2446 | 0.360 |
Why?
|
E2F2 Transcription Factor | 7 | 2008 | 15 | 0.350 |
Why?
|
Cancer Vaccines | 1 | 2010 | 139 | 0.340 |
Why?
|
Monte Carlo Method | 2 | 2019 | 146 | 0.340 |
Why?
|
HEK293 Cells | 3 | 2021 | 625 | 0.340 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2008 | 26 | 0.330 |
Why?
|
Blotting, Western | 8 | 2015 | 1195 | 0.330 |
Why?
|
Cellular Microenvironment | 2 | 2020 | 79 | 0.320 |
Why?
|
CDC2-CDC28 Kinases | 5 | 2002 | 18 | 0.310 |
Why?
|
Drug Resistance | 1 | 2008 | 167 | 0.310 |
Why?
|
Trans-Activators | 4 | 2021 | 373 | 0.310 |
Why?
|
Stem Cell Niche | 3 | 2020 | 43 | 0.300 |
Why?
|
Purines | 1 | 2008 | 161 | 0.300 |
Why?
|
Adenovirus E4 Proteins | 1 | 2006 | 2 | 0.290 |
Why?
|
Adenovirus E1A Proteins | 1 | 2006 | 11 | 0.290 |
Why?
|
Tumor Cells, Cultured | 6 | 2019 | 874 | 0.290 |
Why?
|
Cyclosporine | 4 | 2014 | 173 | 0.280 |
Why?
|
Disease Models, Animal | 5 | 2019 | 3730 | 0.280 |
Why?
|
Genes, ras | 2 | 2006 | 95 | 0.280 |
Why?
|
Retinoblastoma-Binding Protein 1 | 16 | 2000 | 22 | 0.270 |
Why?
|
Female | 27 | 2021 | 61588 | 0.270 |
Why?
|
Stochastic Processes | 2 | 2016 | 66 | 0.260 |
Why?
|
Survival Analysis | 2 | 2020 | 1267 | 0.260 |
Why?
|
Pyrimidines | 4 | 2019 | 382 | 0.260 |
Why?
|
Calcium | 2 | 2013 | 1171 | 0.260 |
Why?
|
Gene Expression | 6 | 2021 | 1492 | 0.260 |
Why?
|
Gamma Rays | 4 | 2020 | 52 | 0.260 |
Why?
|
Molecular Sequence Data | 11 | 2015 | 2873 | 0.260 |
Why?
|
Reactive Oxygen Species | 3 | 2019 | 576 | 0.250 |
Why?
|
T-Lymphocyte Subsets | 2 | 2005 | 396 | 0.250 |
Why?
|
Quinazolines | 3 | 2016 | 245 | 0.250 |
Why?
|
Lymphoma | 3 | 2015 | 180 | 0.250 |
Why?
|
DNA Damage | 6 | 2014 | 357 | 0.250 |
Why?
|
Phosphorylation | 5 | 2022 | 1634 | 0.240 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 1597 | 0.230 |
Why?
|
Recombinant Fusion Proteins | 7 | 2010 | 653 | 0.220 |
Why?
|
Cell Lineage | 2 | 2021 | 318 | 0.220 |
Why?
|
Imatinib Mesylate | 2 | 2014 | 64 | 0.220 |
Why?
|
Computer Simulation | 2 | 2019 | 922 | 0.220 |
Why?
|
GATA1 Transcription Factor | 1 | 2022 | 13 | 0.220 |
Why?
|
Nucleotides | 2 | 2017 | 112 | 0.220 |
Why?
|
Thymus Gland | 2 | 2003 | 300 | 0.220 |
Why?
|
Everolimus | 1 | 2022 | 64 | 0.220 |
Why?
|
DNA Modification Methylases | 1 | 2022 | 14 | 0.210 |
Why?
|
Gene Transfer Techniques | 4 | 2005 | 154 | 0.210 |
Why?
|
Time Factors | 8 | 2017 | 6414 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 900 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2013 | 69 | 0.210 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 2 | 2020 | 165 | 0.210 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2003 | 634 | 0.210 |
Why?
|
Monocytes | 2 | 2022 | 513 | 0.210 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 2021 | 7 | 0.200 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2012 | 770 | 0.200 |
Why?
|
Transfection | 6 | 2005 | 890 | 0.200 |
Why?
|
Enterovirus | 2 | 2005 | 72 | 0.200 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 540 | 0.200 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2012 | 83 | 0.190 |
Why?
|
Macrophages | 1 | 2008 | 1324 | 0.190 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 982 | 0.190 |
Why?
|
Immunity, Innate | 3 | 2021 | 745 | 0.190 |
Why?
|
Glycolysis | 2 | 2019 | 224 | 0.190 |
Why?
|
Disease Progression | 3 | 2020 | 2490 | 0.190 |
Why?
|
Lymphocytes | 2 | 2001 | 347 | 0.190 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2021 | 54 | 0.190 |
Why?
|
Aged | 5 | 2022 | 19661 | 0.190 |
Why?
|
Securin | 1 | 2020 | 2 | 0.190 |
Why?
|
Air Pollution | 1 | 2023 | 209 | 0.180 |
Why?
|
Whole-Body Irradiation | 1 | 2020 | 72 | 0.180 |
Why?
|
Myeloid-Derived Suppressor Cells | 1 | 2021 | 57 | 0.180 |
Why?
|
Myeloid Cells | 1 | 2021 | 128 | 0.180 |
Why?
|
Risk Factors | 4 | 2022 | 9003 | 0.180 |
Why?
|
Aneuploidy | 1 | 2020 | 88 | 0.180 |
Why?
|
Genotype | 4 | 2014 | 1882 | 0.180 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 150 | 0.180 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2013 | 237 | 0.180 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 369 | 0.180 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 118 | 0.180 |
Why?
|
Janus Kinase 2 | 1 | 2019 | 32 | 0.180 |
Why?
|
Amino Acid Sequence | 6 | 2015 | 2073 | 0.180 |
Why?
|
False Positive Reactions | 1 | 2019 | 115 | 0.170 |
Why?
|
Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2019 | 6 | 0.170 |
Why?
|
Electron Transport Complex II | 1 | 2019 | 24 | 0.170 |
Why?
|
Gene Library | 1 | 2019 | 127 | 0.170 |
Why?
|
Population Density | 1 | 2019 | 96 | 0.170 |
Why?
|
Air Pollutants | 1 | 2023 | 316 | 0.170 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 103 | 0.170 |
Why?
|
Single Molecule Imaging | 1 | 2019 | 35 | 0.170 |
Why?
|
Cell Respiration | 1 | 2019 | 76 | 0.170 |
Why?
|
Survival Rate | 2 | 2020 | 1720 | 0.170 |
Why?
|
Microtubule-Associated Proteins | 3 | 2016 | 188 | 0.170 |
Why?
|
NF-kappa B | 1 | 2003 | 670 | 0.170 |
Why?
|
Drug Synergism | 2 | 2016 | 339 | 0.160 |
Why?
|
SOXB1 Transcription Factors | 1 | 2019 | 61 | 0.160 |
Why?
|
Cause of Death | 1 | 2020 | 380 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2019 | 1175 | 0.160 |
Why?
|
Cytokines | 3 | 2015 | 1900 | 0.160 |
Why?
|
Cysteine | 1 | 2019 | 184 | 0.160 |
Why?
|
Leukocytes | 1 | 2019 | 290 | 0.160 |
Why?
|
Epithelium | 1 | 2019 | 305 | 0.160 |
Why?
|
Stress, Physiological | 1 | 2021 | 415 | 0.160 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 401 | 0.160 |
Why?
|
Wnt Signaling Pathway | 2 | 2016 | 150 | 0.150 |
Why?
|
Metabolism | 1 | 2017 | 39 | 0.150 |
Why?
|
Transcription Factor DP1 | 12 | 2000 | 21 | 0.150 |
Why?
|
Dasatinib | 3 | 2014 | 46 | 0.150 |
Why?
|
Protein Biosynthesis | 1 | 1999 | 397 | 0.150 |
Why?
|
Rad51 Recombinase | 2 | 2007 | 13 | 0.150 |
Why?
|
Colorectal Neoplasms | 2 | 2015 | 628 | 0.150 |
Why?
|
Heredity | 1 | 2017 | 11 | 0.150 |
Why?
|
Bromodeoxyuridine | 5 | 2005 | 76 | 0.150 |
Why?
|
Prognosis | 3 | 2022 | 3443 | 0.150 |
Why?
|
Autophagy | 1 | 2021 | 315 | 0.150 |
Why?
|
Thiazoles | 3 | 2014 | 121 | 0.150 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2016 | 229 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2007 | 109 | 0.150 |
Why?
|
RNA, Messenger | 5 | 2015 | 2661 | 0.150 |
Why?
|
Hydrazines | 1 | 2016 | 31 | 0.140 |
Why?
|
Hydroxyurea | 2 | 2007 | 30 | 0.140 |
Why?
|
Tumor Protein p73 | 3 | 2006 | 15 | 0.140 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 1012 | 0.140 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2019 | 164 | 0.140 |
Why?
|
Carbazoles | 1 | 2016 | 80 | 0.140 |
Why?
|
Interleukin-1 | 1 | 2021 | 980 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2010 | 58 | 0.140 |
Why?
|
Blood Platelets | 1 | 2019 | 369 | 0.140 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 105 | 0.140 |
Why?
|
Thrombosis | 1 | 2019 | 309 | 0.140 |
Why?
|
Recombination, Genetic | 4 | 2007 | 173 | 0.140 |
Why?
|
Glutamic Acid | 1 | 2017 | 224 | 0.140 |
Why?
|
Cancer Survivors | 1 | 2019 | 201 | 0.140 |
Why?
|
Interphase | 1 | 1995 | 30 | 0.140 |
Why?
|
Genetic Drift | 1 | 2015 | 8 | 0.130 |
Why?
|
Middle Aged | 5 | 2020 | 27627 | 0.130 |
Why?
|
Pedigree | 1 | 2017 | 485 | 0.130 |
Why?
|
Fatty Acids | 1 | 2018 | 407 | 0.130 |
Why?
|
DNA Polymerase II | 1 | 1995 | 29 | 0.130 |
Why?
|
Biopsy | 1 | 2019 | 1079 | 0.130 |
Why?
|
Open Reading Frames | 1 | 2016 | 121 | 0.130 |
Why?
|
Protein Isoforms | 3 | 2009 | 345 | 0.130 |
Why?
|
Interferons | 1 | 2016 | 151 | 0.130 |
Why?
|
Embryonic and Fetal Development | 2 | 2000 | 95 | 0.130 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2015 | 14 | 0.130 |
Why?
|
Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2014 | 6 | 0.130 |
Why?
|
Ketone Oxidoreductases | 1 | 2014 | 7 | 0.130 |
Why?
|
Piperidines | 1 | 2016 | 171 | 0.130 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 469 | 0.130 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2014 | 56 | 0.130 |
Why?
|
Amino Acids | 1 | 2018 | 465 | 0.130 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 551 | 0.130 |
Why?
|
Exome | 1 | 2016 | 220 | 0.130 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 1795 | 0.130 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2015 | 333 | 0.130 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 89 | 0.130 |
Why?
|
Phosphoproteins | 3 | 2003 | 308 | 0.130 |
Why?
|
Biomarkers | 6 | 2021 | 3590 | 0.120 |
Why?
|
Promoter Regions, Genetic | 5 | 2011 | 1158 | 0.120 |
Why?
|
Ovalbumin | 2 | 2005 | 165 | 0.120 |
Why?
|
Calcineurin Inhibitors | 1 | 2014 | 61 | 0.120 |
Why?
|
Pancreas | 2 | 2008 | 282 | 0.120 |
Why?
|
Superoxides | 1 | 2014 | 221 | 0.120 |
Why?
|
Gastrula | 1 | 1994 | 21 | 0.120 |
Why?
|
Fibroblasts | 4 | 2016 | 843 | 0.120 |
Why?
|
Saccharomyces cerevisiae | 3 | 2010 | 495 | 0.120 |
Why?
|
Metabolomics | 1 | 2019 | 550 | 0.120 |
Why?
|
Salivary Glands | 1 | 2014 | 32 | 0.120 |
Why?
|
GTPase-Activating Proteins | 1 | 1994 | 71 | 0.120 |
Why?
|
Models, Molecular | 3 | 2010 | 1435 | 0.120 |
Why?
|
Risk | 1 | 2016 | 854 | 0.120 |
Why?
|
Genome, Human | 2 | 2016 | 386 | 0.120 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 965 | 0.120 |
Why?
|
Urothelium | 1 | 2013 | 33 | 0.120 |
Why?
|
Genes | 1 | 1994 | 231 | 0.120 |
Why?
|
Pyrazoles | 1 | 2016 | 363 | 0.120 |
Why?
|
Protein Kinase C-delta | 1 | 2014 | 69 | 0.110 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 176 | 0.110 |
Why?
|
Oncogene Proteins v-erbB | 1 | 2013 | 2 | 0.110 |
Why?
|
Base Sequence | 10 | 2004 | 2160 | 0.110 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 1994 | 84 | 0.110 |
Why?
|
Retroviridae | 3 | 2004 | 89 | 0.110 |
Why?
|
Adenoma | 1 | 2015 | 191 | 0.110 |
Why?
|
Pyridines | 1 | 2016 | 440 | 0.110 |
Why?
|
Smoking | 1 | 2020 | 1487 | 0.110 |
Why?
|
Mitochondrial Proteins | 1 | 2014 | 226 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2021 | 702 | 0.110 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2013 | 63 | 0.110 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2012 | 20 | 0.110 |
Why?
|
Cyclin E | 6 | 2005 | 21 | 0.110 |
Why?
|
Transduction, Genetic | 3 | 2001 | 116 | 0.110 |
Why?
|
Protein Structure, Tertiary | 3 | 2010 | 823 | 0.110 |
Why?
|
Benzimidazoles | 1 | 2013 | 140 | 0.110 |
Why?
|
Cyclins | 3 | 1997 | 82 | 0.100 |
Why?
|
Lymphocyte Activation | 3 | 2005 | 1067 | 0.100 |
Why?
|
Child | 4 | 2022 | 19137 | 0.100 |
Why?
|
E2F3 Transcription Factor | 3 | 2002 | 8 | 0.100 |
Why?
|
Algorithms | 1 | 2019 | 1543 | 0.100 |
Why?
|
Repressor Proteins | 1 | 2015 | 377 | 0.100 |
Why?
|
Sarcoma | 1 | 2013 | 137 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2015 | 502 | 0.100 |
Why?
|
Proteins | 2 | 1996 | 938 | 0.100 |
Why?
|
Piperazines | 2 | 2012 | 316 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 2062 | 0.100 |
Why?
|
Urinary Bladder | 1 | 2013 | 180 | 0.100 |
Why?
|
Male | 13 | 2021 | 57818 | 0.100 |
Why?
|
Mice, Nude | 2 | 2012 | 663 | 0.100 |
Why?
|
Risk Assessment | 1 | 2020 | 3057 | 0.100 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 47 | 0.100 |
Why?
|
Interleukin-7 | 1 | 2010 | 44 | 0.100 |
Why?
|
Cell Movement | 1 | 2015 | 897 | 0.090 |
Why?
|
Receptor, ErbB-2 | 1 | 2013 | 320 | 0.090 |
Why?
|
Genes, MHC Class I | 1 | 2010 | 33 | 0.090 |
Why?
|
Vaccines, Synthetic | 1 | 2010 | 128 | 0.090 |
Why?
|
Benzamides | 1 | 2010 | 176 | 0.090 |
Why?
|
Cyclophilin A | 1 | 2009 | 24 | 0.090 |
Why?
|
Basigin | 1 | 2009 | 27 | 0.090 |
Why?
|
Genes, Retinoblastoma | 3 | 2006 | 9 | 0.090 |
Why?
|
Genetic Therapy | 1 | 2011 | 267 | 0.090 |
Why?
|
Ovarian Neoplasms | 1 | 2014 | 420 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2011 | 181 | 0.090 |
Why?
|
Genes, Tumor Suppressor | 3 | 2004 | 77 | 0.080 |
Why?
|
Conserved Sequence | 2 | 2003 | 219 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2010 | 649 | 0.080 |
Why?
|
Aged, 80 and over | 1 | 2020 | 6562 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2005 | 985 | 0.080 |
Why?
|
Lentivirus | 1 | 2008 | 52 | 0.080 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2008 | 12 | 0.080 |
Why?
|
Publishing | 1 | 2009 | 131 | 0.080 |
Why?
|
Protein Kinases | 2 | 2007 | 310 | 0.080 |
Why?
|
Luminescent Proteins | 3 | 2004 | 174 | 0.080 |
Why?
|
Pancreatitis, Chronic | 1 | 2008 | 39 | 0.080 |
Why?
|
Protein Folding | 1 | 2009 | 250 | 0.080 |
Why?
|
Cyclin-Dependent Kinase 2 | 5 | 2002 | 32 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2013 | 471 | 0.080 |
Why?
|
Herpes Simplex Virus Protein Vmw65 | 1 | 2007 | 5 | 0.080 |
Why?
|
Aphidicolin | 1 | 2007 | 6 | 0.080 |
Why?
|
Checkpoint Kinase 1 | 1 | 2007 | 27 | 0.080 |
Why?
|
Recombinant Proteins | 6 | 2009 | 1308 | 0.080 |
Why?
|
Gene Knockdown Techniques | 1 | 2008 | 311 | 0.080 |
Why?
|
Pancreatitis | 1 | 2008 | 108 | 0.070 |
Why?
|
Etoposide | 1 | 2007 | 149 | 0.070 |
Why?
|
Rats | 7 | 2007 | 5394 | 0.070 |
Why?
|
Killer Cells, Natural | 1 | 2010 | 381 | 0.070 |
Why?
|
Green Fluorescent Proteins | 3 | 2004 | 395 | 0.070 |
Why?
|
Keratinocytes | 3 | 2005 | 227 | 0.070 |
Why?
|
Substantia Nigra | 1 | 2007 | 38 | 0.070 |
Why?
|
Protein Binding | 3 | 2014 | 1975 | 0.070 |
Why?
|
Th2 Cells | 2 | 2005 | 164 | 0.070 |
Why?
|
Organ Specificity | 3 | 2016 | 278 | 0.070 |
Why?
|
Sulfonamides | 2 | 2020 | 445 | 0.070 |
Why?
|
Immunotherapy | 1 | 2010 | 493 | 0.070 |
Why?
|
Up-Regulation | 2 | 2007 | 872 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 683 | 0.070 |
Why?
|
Interneurons | 1 | 2007 | 103 | 0.070 |
Why?
|
Coxsackie and Adenovirus Receptor-Like Membrane Protein | 3 | 2001 | 7 | 0.070 |
Why?
|
Environmental Pollutants | 1 | 2007 | 120 | 0.070 |
Why?
|
Flavonoids | 2 | 2003 | 71 | 0.070 |
Why?
|
Genes, Fungal | 2 | 1996 | 49 | 0.070 |
Why?
|
Mice, Inbred DBA | 1 | 2005 | 174 | 0.070 |
Why?
|
Skin Transplantation | 1 | 2005 | 58 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2010 | 770 | 0.060 |
Why?
|
Genes, abl | 1 | 2004 | 3 | 0.060 |
Why?
|
ras Proteins | 2 | 2013 | 141 | 0.060 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2005 | 134 | 0.060 |
Why?
|
Blotting, Northern | 4 | 2003 | 194 | 0.060 |
Why?
|
Cloning, Molecular | 2 | 2003 | 546 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 293 | 0.060 |
Why?
|
Ultraviolet Rays | 2 | 2005 | 381 | 0.060 |
Why?
|
Polyploidy | 1 | 2003 | 17 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2015 | 372 | 0.060 |
Why?
|
Drosophila melanogaster | 1 | 2005 | 200 | 0.060 |
Why?
|
Spleen | 2 | 2005 | 510 | 0.060 |
Why?
|
Injections, Intraperitoneal | 1 | 2003 | 108 | 0.060 |
Why?
|
Genes, Lethal | 2 | 2012 | 25 | 0.060 |
Why?
|
Erythropoiesis | 1 | 2003 | 33 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2016 | 1056 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2007 | 539 | 0.060 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2003 | 9 | 0.060 |
Why?
|
Neomycin | 1 | 2003 | 6 | 0.060 |
Why?
|
Immunologic Memory | 1 | 2005 | 313 | 0.060 |
Why?
|
Mutagenesis, Insertional | 2 | 1994 | 61 | 0.060 |
Why?
|
Chromatin | 2 | 2004 | 441 | 0.060 |
Why?
|
Interleukin-10 | 1 | 2005 | 306 | 0.060 |
Why?
|
Drug Resistance, Microbial | 1 | 2003 | 67 | 0.060 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 1998 | 348 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2007 | 334 | 0.050 |
Why?
|
Mice, Mutant Strains | 1 | 2003 | 280 | 0.050 |
Why?
|
Graft Survival | 1 | 2005 | 504 | 0.050 |
Why?
|
beta-Galactosidase | 2 | 2013 | 65 | 0.050 |
Why?
|
3' Untranslated Regions | 1 | 2003 | 142 | 0.050 |
Why?
|
Eukaryotic Cells | 1 | 2002 | 34 | 0.050 |
Why?
|
Mutagenesis | 1 | 2003 | 176 | 0.050 |
Why?
|
Gene Targeting | 1 | 2002 | 80 | 0.050 |
Why?
|
Transplantation, Homologous | 1 | 2003 | 415 | 0.050 |
Why?
|
Alveolar Epithelial Cells | 1 | 2023 | 102 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2014 | 1965 | 0.050 |
Why?
|
Ribonucleases | 1 | 2001 | 53 | 0.050 |
Why?
|
Particle Size | 1 | 2023 | 345 | 0.050 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2002 | 103 | 0.050 |
Why?
|
Autophagosomes | 1 | 2021 | 21 | 0.050 |
Why?
|
Carcinoma, Basal Cell | 1 | 2002 | 67 | 0.050 |
Why?
|
Adenovirus E2 Proteins | 1 | 2000 | 1 | 0.050 |
Why?
|
Drosophila | 1 | 2002 | 140 | 0.050 |
Why?
|
Particulate Matter | 1 | 2023 | 244 | 0.050 |
Why?
|
In Vitro Techniques | 1 | 2003 | 1096 | 0.050 |
Why?
|
Autophagy-Related Proteins | 1 | 2021 | 46 | 0.050 |
Why?
|
Cell Nucleus | 3 | 2014 | 580 | 0.050 |
Why?
|
Rhabdomyosarcoma | 1 | 2001 | 57 | 0.050 |
Why?
|
Prolactin | 1 | 2000 | 96 | 0.050 |
Why?
|
Biological Assay | 1 | 2021 | 122 | 0.050 |
Why?
|
In Situ Hybridization | 2 | 2007 | 311 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 116 | 0.050 |
Why?
|
Lysosomes | 1 | 2021 | 136 | 0.050 |
Why?
|
Niacinamide | 1 | 2020 | 70 | 0.050 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 155 | 0.050 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 2019 | 2 | 0.050 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 1999 | 6 | 0.050 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2002 | 192 | 0.050 |
Why?
|
Immunohistochemistry | 4 | 2007 | 1691 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2019 | 43 | 0.050 |
Why?
|
Superantigens | 1 | 1999 | 68 | 0.040 |
Why?
|
Macrophages, Alveolar | 1 | 2023 | 359 | 0.040 |
Why?
|
Ribonucleoproteins | 1 | 2000 | 88 | 0.040 |
Why?
|
Adipocytes | 1 | 2001 | 199 | 0.040 |
Why?
|
Megakaryocytes | 1 | 2019 | 30 | 0.040 |
Why?
|
Embryonic Development | 1 | 2000 | 119 | 0.040 |
Why?
|
Cohort Studies | 2 | 2023 | 5117 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 1997 | 69 | 0.040 |
Why?
|
Succinate Dehydrogenase | 1 | 2019 | 44 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2005 | 963 | 0.040 |
Why?
|
Nanog Homeobox Protein | 1 | 2019 | 11 | 0.040 |
Why?
|
Platelet Activation | 1 | 2019 | 70 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2023 | 405 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2003 | 702 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2001 | 455 | 0.040 |
Why?
|
Antigens, Viral | 1 | 1999 | 181 | 0.040 |
Why?
|
Caenorhabditis elegans | 1 | 2002 | 287 | 0.040 |
Why?
|
Thymus Neoplasms | 1 | 1998 | 21 | 0.040 |
Why?
|
Thymoma | 1 | 1998 | 31 | 0.040 |
Why?
|
Fas Ligand Protein | 1 | 1998 | 60 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 356 | 0.040 |
Why?
|
Integrases | 2 | 2013 | 123 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2003 | 671 | 0.040 |
Why?
|
Mitosis | 2 | 1999 | 172 | 0.040 |
Why?
|
RNA | 2 | 2003 | 833 | 0.040 |
Why?
|
Microscopy, Fluorescence | 2 | 2014 | 412 | 0.040 |
Why?
|
fas Receptor | 1 | 1998 | 98 | 0.040 |
Why?
|
Doxorubicin | 1 | 1999 | 302 | 0.040 |
Why?
|
Sarcopenia | 1 | 2019 | 72 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2013 | 410 | 0.040 |
Why?
|
Mice, SCID | 1 | 2019 | 333 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 359 | 0.040 |
Why?
|
Cell Physiological Phenomena | 1 | 1997 | 23 | 0.040 |
Why?
|
Azacitidine | 1 | 2018 | 119 | 0.040 |
Why?
|
Dexamethasone | 1 | 1999 | 320 | 0.040 |
Why?
|
Biological Transport | 1 | 2018 | 382 | 0.040 |
Why?
|
Glutathione | 1 | 2019 | 324 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 226 | 0.040 |
Why?
|
Frailty | 1 | 2019 | 116 | 0.040 |
Why?
|
Resting Phase, Cell Cycle | 1 | 1996 | 15 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2015 | 3173 | 0.040 |
Why?
|
Restriction Mapping | 2 | 1994 | 76 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 439 | 0.040 |
Why?
|
3T3 Cells | 3 | 2004 | 141 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 544 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 1998 | 446 | 0.040 |
Why?
|
Heart Diseases | 1 | 2019 | 341 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 817 | 0.030 |
Why?
|
G2 Phase | 1 | 1995 | 33 | 0.030 |
Why?
|
Thymidylate Synthase | 1 | 1995 | 11 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 1995 | 55 | 0.030 |
Why?
|
Metabolome | 1 | 2018 | 296 | 0.030 |
Why?
|
Ribonucleotide Reductases | 1 | 1995 | 30 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 693 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2018 | 477 | 0.030 |
Why?
|
Twist-Related Protein 1 | 1 | 2015 | 10 | 0.030 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2015 | 55 | 0.030 |
Why?
|
Cognitive Dysfunction | 1 | 2019 | 301 | 0.030 |
Why?
|
Plasmids | 1 | 1995 | 355 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2014 | 7 | 0.030 |
Why?
|
Cell Transformation, Viral | 1 | 1994 | 22 | 0.030 |
Why?
|
Blood Glucose | 1 | 2003 | 1946 | 0.030 |
Why?
|
alpha Karyopherins | 1 | 2014 | 15 | 0.030 |
Why?
|
Cyclin A | 2 | 2005 | 15 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2016 | 300 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1994 | 155 | 0.030 |
Why?
|
Gene Amplification | 1 | 2014 | 97 | 0.030 |
Why?
|
Arginine | 1 | 2015 | 249 | 0.030 |
Why?
|
Ectoderm | 1 | 1994 | 43 | 0.030 |
Why?
|
Cadherins | 1 | 2015 | 186 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2014 | 171 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2014 | 113 | 0.030 |
Why?
|
Breeding | 1 | 2013 | 56 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 394 | 0.030 |
Why?
|
Insulin | 1 | 2003 | 2170 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 462 | 0.030 |
Why?
|
Chronic Disease | 1 | 2019 | 1637 | 0.030 |
Why?
|
Gene Dosage | 1 | 2014 | 136 | 0.030 |
Why?
|
src-Family Kinases | 1 | 2014 | 90 | 0.030 |
Why?
|
Leucine | 1 | 1994 | 117 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1994 | 130 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1994 | 336 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 167 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2013 | 146 | 0.030 |
Why?
|
Tyrosine | 1 | 2014 | 233 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 1994 | 134 | 0.030 |
Why?
|
Keratins | 1 | 2013 | 174 | 0.030 |
Why?
|
Hyperplasia | 1 | 2013 | 170 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2013 | 71 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 452 | 0.030 |
Why?
|
Wound Healing | 1 | 2015 | 270 | 0.030 |
Why?
|
Genes, Synthetic | 1 | 2012 | 14 | 0.030 |
Why?
|
Neurons | 1 | 2000 | 1345 | 0.030 |
Why?
|
Gene Deletion | 1 | 2014 | 361 | 0.030 |
Why?
|
RNA, Untranslated | 1 | 2013 | 115 | 0.030 |
Why?
|
Proviruses | 2 | 2003 | 9 | 0.030 |
Why?
|
Drug Discovery | 1 | 2013 | 124 | 0.030 |
Why?
|
Virus Integration | 2 | 2003 | 71 | 0.030 |
Why?
|
Calcium Signaling | 1 | 2013 | 219 | 0.020 |
Why?
|
Moloney murine leukemia virus | 1 | 1991 | 11 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 239 | 0.020 |
Why?
|
Imidazoles | 1 | 2012 | 232 | 0.020 |
Why?
|
Ear | 1 | 2011 | 33 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2002 | 268 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 1991 | 73 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1991 | 103 | 0.020 |
Why?
|
DNA Methylation | 1 | 2015 | 503 | 0.020 |
Why?
|
RNA, Viral | 1 | 1994 | 572 | 0.020 |
Why?
|
DNA Probes | 2 | 2002 | 60 | 0.020 |
Why?
|
Down-Regulation | 2 | 2003 | 627 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2019 | 4596 | 0.020 |
Why?
|
Syndecan-1 | 1 | 2009 | 30 | 0.020 |
Why?
|
Catalysis | 1 | 2009 | 295 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2009 | 338 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 968 | 0.020 |
Why?
|
Cell Line, Transformed | 2 | 2002 | 136 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2000 | 828 | 0.020 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2007 | 2 | 0.020 |
Why?
|
1-Methyl-4-phenylpyridinium | 1 | 2007 | 5 | 0.020 |
Why?
|
Information Dissemination | 1 | 2009 | 210 | 0.020 |
Why?
|
Mammals | 2 | 2002 | 253 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2009 | 613 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2007 | 100 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2013 | 2874 | 0.020 |
Why?
|
HeLa Cells | 2 | 1998 | 583 | 0.020 |
Why?
|
Cyclin B | 1 | 2005 | 14 | 0.020 |
Why?
|
Mitomycin | 1 | 2005 | 27 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2005 | 48 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2007 | 490 | 0.020 |
Why?
|
Kinetics | 2 | 2000 | 1625 | 0.020 |
Why?
|
Cytosol | 1 | 2005 | 221 | 0.020 |
Why?
|
Cornea | 1 | 2005 | 117 | 0.020 |
Why?
|
Aldehydes | 1 | 2005 | 154 | 0.020 |
Why?
|
Tacrolimus | 1 | 2005 | 151 | 0.020 |
Why?
|
GATA3 Transcription Factor | 1 | 2004 | 26 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 314 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2007 | 1295 | 0.010 |
Why?
|
Research Design | 1 | 2009 | 969 | 0.010 |
Why?
|
Acetylation | 1 | 2004 | 217 | 0.010 |
Why?
|
Transgenes | 1 | 2004 | 174 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 6477 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2003 | 129 | 0.010 |
Why?
|
United States | 1 | 2019 | 12557 | 0.010 |
Why?
|
RNA Splice Sites | 1 | 2003 | 35 | 0.010 |
Why?
|
Caspases | 1 | 2004 | 269 | 0.010 |
Why?
|
Sunlight | 1 | 2003 | 60 | 0.010 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2002 | 5 | 0.010 |
Why?
|
Polyadenylation | 1 | 2003 | 38 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2002 | 134 | 0.010 |
Why?
|
Centrosome | 1 | 2002 | 59 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2002 | 77 | 0.010 |
Why?
|
Cell Fractionation | 1 | 2002 | 53 | 0.010 |
Why?
|
Thymidine | 1 | 2002 | 62 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 3175 | 0.010 |
Why?
|
Viral Proteins | 1 | 2004 | 296 | 0.010 |
Why?
|
Integrin alphaV | 1 | 2001 | 4 | 0.010 |
Why?
|
RNA Splicing | 1 | 2003 | 243 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2000 | 16 | 0.010 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2000 | 24 | 0.010 |
Why?
|
Interleukin-3 | 1 | 2000 | 25 | 0.010 |
Why?
|
Receptors, Prolactin | 1 | 2000 | 9 | 0.010 |
Why?
|
Ganglia, Spinal | 1 | 2000 | 45 | 0.010 |
Why?
|
Laminin | 1 | 2000 | 68 | 0.010 |
Why?
|
Capsid | 1 | 2001 | 77 | 0.010 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2000 | 2 | 0.010 |
Why?
|
Granulocytes | 1 | 2000 | 79 | 0.010 |
Why?
|
Blastomeres | 1 | 2000 | 12 | 0.010 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2000 | 19 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2000 | 97 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 9346 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 155 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 173 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2000 | 311 | 0.010 |
Why?
|
Antibodies | 1 | 2002 | 392 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2000 | 522 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 1999 | 46 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 299 | 0.010 |
Why?
|
Genes, myc | 1 | 1999 | 46 | 0.010 |
Why?
|
Histones | 1 | 2004 | 552 | 0.010 |
Why?
|
Half-Life | 1 | 1999 | 147 | 0.010 |
Why?
|
Species Specificity | 1 | 2000 | 565 | 0.010 |
Why?
|
Minichromosome Maintenance Complex Component 3 | 1 | 1998 | 2 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2005 | 1179 | 0.010 |
Why?
|
Antigens, CD | 1 | 2001 | 460 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 175 | 0.010 |
Why?
|
Sheep | 1 | 2000 | 764 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 1998 | 65 | 0.010 |
Why?
|
Phosphorus Radioisotopes | 1 | 1997 | 29 | 0.010 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 1996 | 2 | 0.010 |
Why?
|
Autoradiography | 1 | 1997 | 72 | 0.010 |
Why?
|
Origin Recognition Complex | 1 | 1996 | 3 | 0.010 |
Why?
|
Cyclin D | 1 | 1996 | 6 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1997 | 332 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 1996 | 32 | 0.010 |
Why?
|
Genomic Library | 1 | 1995 | 14 | 0.010 |
Why?
|
Pregnancy | 2 | 2000 | 5694 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 1996 | 37 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1995 | 205 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1995 | 139 | 0.010 |
Why?
|
Hydrolysis | 1 | 1995 | 176 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1995 | 364 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1996 | 216 | 0.010 |
Why?
|
Kanamycin Kinase | 1 | 1992 | 3 | 0.010 |
Why?
|
Phosphotransferases | 1 | 1992 | 27 | 0.010 |
Why?
|
Adult | 1 | 2014 | 31525 | 0.010 |
Why?
|
Binding Sites | 1 | 1995 | 1224 | 0.010 |
Why?
|
Chimera | 1 | 1992 | 60 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2003 | 5256 | 0.010 |
Why?
|
Alcohol Oxidoreductases | 1 | 1992 | 57 | 0.010 |
Why?
|
Adenovirus Early Proteins | 1 | 1991 | 2 | 0.010 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1991 | 14 | 0.010 |
Why?
|
Mesocricetus | 1 | 1991 | 31 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1991 | 46 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 1991 | 62 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1991 | 35 | 0.010 |
Why?
|
Adolescent | 1 | 2010 | 18483 | 0.010 |
Why?
|
Oncogene Proteins, Viral | 1 | 1991 | 20 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1991 | 67 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1991 | 84 | 0.010 |
Why?
|
Cricetinae | 1 | 1991 | 263 | 0.010 |
Why?
|
Poly A | 1 | 1991 | 47 | 0.010 |
Why?
|
Methionine | 1 | 1991 | 145 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1991 | 158 | 0.010 |
Why?
|
Placenta | 1 | 1995 | 641 | 0.010 |
Why?
|
Escherichia coli | 1 | 1991 | 758 | 0.000 |
Why?
|